I caught-up with Molecule Software’s leadership team of Sameer Soleja and Sam Parka recently to get an update on the company’s on-going development from both a product and sales perspective. As readers of the this blog and followers of the company know, Molecule takes pride in having crafted a different kind of company (with a decidedly Silicon Valley vibe) and different kind of product…
In development for about 3 years now, the product has been purpose-built for the cloud and has a front-end that feels more “App” than “application”. With an innovative “natural language” deal capture capability, a heavy reliance on automation of data flow, and a look-and-feel that separates the product from the traditional grey screens found in this industry, the product definitely comes across as “new school”.
In its earlier releases, Molecule capabilities were primarily deal capture (either entered on the front-end or via exchange deal feeds) and position management. In our conversation, Sam and Sameer noted several new developments over the last year that have helped round out the product’s capabilities, including a Monte Carlo VAR that they say runs in “near real-time”, and a number of new connections to price & data feeds, markets, exchanges and FCM’s that help expedite data transfer and accelerate information flow for users. Though not yet a system that addresses the needs of all physical commodity market segments; with the capabilities they have currently deployed, Molecule has developed good sales traction – closing business with several hedge funds and merchant energy firms, providing coverage of financial commodities and some physical as well.
Though unannounced and limited in what they could disclose, Sameer did indicate that their client roster just got significant boost with the recent signing of a Fortune 500 global financial services firm – in a deal fought and won against one of the traditional heavy-weight CTRM vendors. This win is clearly a good sign for company and indicative that they are definitely moving in the right direction in terms of strategy and product capabilities.